Humana, one of the nation's largest health care companies, and Pfizer, the world's largest biopharmaceutical company, have recently linked together to explore new ideas and ways to improve the quality, outcomes and costs of the health care delivery system for senior citizens and other population.
The firms have signed a five-year partnership to study "key issues and deliver interventions to reduce inefficiencies in the management of chronic conditions such as pain, cardiovascular disease, and Alzheimer’s disease". Pfizer and Humana cited figures which suggest that over the next 10 years, "the Medicare-eligible population is expected to grow to 65 million – a 36% increase from 2010".
William Fleming, Vice President of Humana Pharmacy Solutions, said the companies will "strive to develop an important body of knowledge that may meaningfully advance the work of our respective companies in various disease areas, population health sub-types, and intervention methods, among other things".
According to the US. Census Bureau Population Projections, over the next 10 years the Medicare-eligible population is expected to grow to 65 million – a 36 percent increase from 2010. With this significant and growing population, along with the need to more efficiently use health care resources and reduce costs, it makes sense for two leading health care companies to join forces and address these challenges.
Humana Inc., headquartered in Louisville, Kentucky, is a leading healthcare company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in healthcare that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.